Curebase Unlocks Drug Development With Remote Clinical Trials; Raises $15M Led By GGV Capital

The financing was led by GGV Capital with participation from Xfund, Bold Capital, and several other institutional funds, and brings the total raised to $19M.  Jeff Richards, managing partner, GGV Capital will join the board of directors.
（以上内容由医药魔方AI生成）